Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains重组抗体|科研级 Diridavumab ( 地利伏单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains重组抗体|科研级 Diridavumab ( 地利伏单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains重组抗体|科研级 Diridavumab ( 地利伏单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1335

Alias

科研级 Diridavumab ( 地利伏单抗 ), Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab

Molecular Name

Diridavumab

Size

1mg, 5mg

CAS Number

1393659-46-5

Isotype

IgG1 Lambda

Clonality

Monoclonal

Concentration

1mg/ml

Applications

FCM

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

influenza A virus hemagglutinin HA2 subunit from various strains[Influenza A virus]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ